BioMerieux

DNA
MedTech

Oxford Nanopore, bioMérieux explore infectious disease tests

The collaboration will begin by focusing on “selected opportunities” in the field, such as determining the antibiotic resistance of tuberculosis.
Conor Hale Apr 14, 2023 12:00pm
Antibiotic-resistant bacteria

Boehringer rounds up allies to build €40M anti-superbug startup

Jul 6, 2022 6:01am
FDA sign

FDA deems bioMérieux assay tech recall Class I

Aug 16, 2016 11:29am